Association between

IL-27 has potent antitumor effects. We aimed to examine the contribution of single nucleotide polymorphisms in - to the risk of papillary thyroid carcinoma (PTC). - rs153109 and rs17855750 were analyzed in 496 PTC patients and 629 controls, using a polymerase chain reaction-restriction fragment leng...

Full description

Saved in:
Bibliographic Details
Published in:Biomarkers in medicine 2017-02, Vol.11 (2), p.141-149
Main Authors: Nie, Xinwen, Yuan, Fang, Chen, Peng, Pu, Yan, Zhu, Jingqiang, Wang, Yichao, Xiao, Xue, Che, Guanglu, Gao, Linbo, Zhang, Lin
Format: Article
Language:English
Subjects:
papillary thyroid carcinoma
risk
rs153109
rs17855750
single nucleotide polymorphism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 149
container_issue 2
container_start_page 141
container_title Biomarkers in medicine
container_volume 11
creator Nie, Xinwen
Yuan, Fang
Chen, Peng
Pu, Yan
Zhu, Jingqiang
Wang, Yichao
Xiao, Xue
Che, Guanglu
Gao, Linbo
Zhang, Lin
description IL-27 has potent antitumor effects. We aimed to examine the contribution of single nucleotide polymorphisms in - to the risk of papillary thyroid carcinoma (PTC). - rs153109 and rs17855750 were analyzed in 496 PTC patients and 629 controls, using a polymerase chain reaction-restriction fragment length polymorphism method. The rs153109 AG and AG/GG genotypes were significantly associated with increased risks for PTC. Significantly increased PTC risk was also associated with rs17855750 GT and GT/GG genotypes. Combined genotypes of rs153109 AG/GG and rs17855750 GT/GG increased the risk of PTC (p < 0.05). These findings showed that - rs153109 and rs17855750 might be related to the tumorigenesis of PTC.
doi_str_mv 10.2217/bmm-2016-0283
format article
fullrecord <record><control><sourceid>futurescience</sourceid><recordid>TN_cdi_futurescience_futuremedicine_10_2217_bmm_2016_0283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_2217_bmm_2016_0283</sourcerecordid><originalsourceid>FETCH-futurescience_futuremedicine_10_2217_bmm_2016_02833</originalsourceid><addsrcrecordid>eNpjYBA1NNAzMjI010_KzdU1MjA00zUwsjBmYuA0NDc10jUwNjdkgbPNjDkYuIqLswwMTM3NzYw4GYQdi4vzkzMTSzLz8xSSUkvKU1PzeBhY0xJzilN5oTQ3g6Wba4izh25aaUlpUWpxcmZqXnJqPISXm5qSmZyZlxpvaBAPckU80BXxIFfEg1xhTIleACLQPkY</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Association between</title><source>PubMed Central</source><creator>Nie, Xinwen ; Yuan, Fang ; Chen, Peng ; Pu, Yan ; Zhu, Jingqiang ; Wang, Yichao ; Xiao, Xue ; Che, Guanglu ; Gao, Linbo ; Zhang, Lin</creator><creatorcontrib>Nie, Xinwen ; Yuan, Fang ; Chen, Peng ; Pu, Yan ; Zhu, Jingqiang ; Wang, Yichao ; Xiao, Xue ; Che, Guanglu ; Gao, Linbo ; Zhang, Lin</creatorcontrib><description>IL-27 has potent antitumor effects. We aimed to examine the contribution of single nucleotide polymorphisms in - to the risk of papillary thyroid carcinoma (PTC). - rs153109 and rs17855750 were analyzed in 496 PTC patients and 629 controls, using a polymerase chain reaction-restriction fragment length polymorphism method. The rs153109 AG and AG/GG genotypes were significantly associated with increased risks for PTC. Significantly increased PTC risk was also associated with rs17855750 GT and GT/GG genotypes. Combined genotypes of rs153109 AG/GG and rs17855750 GT/GG increased the risk of PTC (p &lt; 0.05). These findings showed that - rs153109 and rs17855750 might be related to the tumorigenesis of PTC.</description><identifier>ISSN: 1752-0363</identifier><identifier>EISSN: 1752-0371</identifier><identifier>DOI: 10.2217/bmm-2016-0283</identifier><language>eng</language><publisher>Future Medicine Ltd</publisher><subject>papillary thyroid carcinoma ; risk ; rs153109 ; rs17855750 ; single nucleotide polymorphism</subject><ispartof>Biomarkers in medicine, 2017-02, Vol.11 (2), p.141-149</ispartof><rights>Future Medicine Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,783,787,27936,27937</link.rule.ids></links><search><creatorcontrib>Nie, Xinwen</creatorcontrib><creatorcontrib>Yuan, Fang</creatorcontrib><creatorcontrib>Chen, Peng</creatorcontrib><creatorcontrib>Pu, Yan</creatorcontrib><creatorcontrib>Zhu, Jingqiang</creatorcontrib><creatorcontrib>Wang, Yichao</creatorcontrib><creatorcontrib>Xiao, Xue</creatorcontrib><creatorcontrib>Che, Guanglu</creatorcontrib><creatorcontrib>Gao, Linbo</creatorcontrib><creatorcontrib>Zhang, Lin</creatorcontrib><title>Association between</title><title>Biomarkers in medicine</title><description>IL-27 has potent antitumor effects. We aimed to examine the contribution of single nucleotide polymorphisms in - to the risk of papillary thyroid carcinoma (PTC). - rs153109 and rs17855750 were analyzed in 496 PTC patients and 629 controls, using a polymerase chain reaction-restriction fragment length polymorphism method. The rs153109 AG and AG/GG genotypes were significantly associated with increased risks for PTC. Significantly increased PTC risk was also associated with rs17855750 GT and GT/GG genotypes. Combined genotypes of rs153109 AG/GG and rs17855750 GT/GG increased the risk of PTC (p &lt; 0.05). These findings showed that - rs153109 and rs17855750 might be related to the tumorigenesis of PTC.</description><subject>papillary thyroid carcinoma</subject><subject>risk</subject><subject>rs153109</subject><subject>rs17855750</subject><subject>single nucleotide polymorphism</subject><issn>1752-0363</issn><issn>1752-0371</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpjYBA1NNAzMjI010_KzdU1MjA00zUwsjBmYuA0NDc10jUwNjdkgbPNjDkYuIqLswwMTM3NzYw4GYQdi4vzkzMTSzLz8xSSUkvKU1PzeBhY0xJzilN5oTQ3g6Wba4izh25aaUlpUWpxcmZqXnJqPISXm5qSmZyZlxpvaBAPckU80BXxIFfEg1xhTIleACLQPkY</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Nie, Xinwen</creator><creator>Yuan, Fang</creator><creator>Chen, Peng</creator><creator>Pu, Yan</creator><creator>Zhu, Jingqiang</creator><creator>Wang, Yichao</creator><creator>Xiao, Xue</creator><creator>Che, Guanglu</creator><creator>Gao, Linbo</creator><creator>Zhang, Lin</creator><general>Future Medicine Ltd</general><scope/></search><sort><creationdate>20170201</creationdate><title>Association between</title><author>Nie, Xinwen ; Yuan, Fang ; Chen, Peng ; Pu, Yan ; Zhu, Jingqiang ; Wang, Yichao ; Xiao, Xue ; Che, Guanglu ; Gao, Linbo ; Zhang, Lin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-futurescience_futuremedicine_10_2217_bmm_2016_02833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>papillary thyroid carcinoma</topic><topic>risk</topic><topic>rs153109</topic><topic>rs17855750</topic><topic>single nucleotide polymorphism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nie, Xinwen</creatorcontrib><creatorcontrib>Yuan, Fang</creatorcontrib><creatorcontrib>Chen, Peng</creatorcontrib><creatorcontrib>Pu, Yan</creatorcontrib><creatorcontrib>Zhu, Jingqiang</creatorcontrib><creatorcontrib>Wang, Yichao</creatorcontrib><creatorcontrib>Xiao, Xue</creatorcontrib><creatorcontrib>Che, Guanglu</creatorcontrib><creatorcontrib>Gao, Linbo</creatorcontrib><creatorcontrib>Zhang, Lin</creatorcontrib><jtitle>Biomarkers in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nie, Xinwen</au><au>Yuan, Fang</au><au>Chen, Peng</au><au>Pu, Yan</au><au>Zhu, Jingqiang</au><au>Wang, Yichao</au><au>Xiao, Xue</au><au>Che, Guanglu</au><au>Gao, Linbo</au><au>Zhang, Lin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between</atitle><jtitle>Biomarkers in medicine</jtitle><date>2017-02-01</date><risdate>2017</risdate><volume>11</volume><issue>2</issue><spage>141</spage><epage>149</epage><pages>141-149</pages><issn>1752-0363</issn><eissn>1752-0371</eissn><abstract>IL-27 has potent antitumor effects. We aimed to examine the contribution of single nucleotide polymorphisms in - to the risk of papillary thyroid carcinoma (PTC). - rs153109 and rs17855750 were analyzed in 496 PTC patients and 629 controls, using a polymerase chain reaction-restriction fragment length polymorphism method. The rs153109 AG and AG/GG genotypes were significantly associated with increased risks for PTC. Significantly increased PTC risk was also associated with rs17855750 GT and GT/GG genotypes. Combined genotypes of rs153109 AG/GG and rs17855750 GT/GG increased the risk of PTC (p &lt; 0.05). These findings showed that - rs153109 and rs17855750 might be related to the tumorigenesis of PTC.</abstract><pub>Future Medicine Ltd</pub><doi>10.2217/bmm-2016-0283</doi></addata></record>
fulltext fulltext
identifier ISSN: 1752-0363
ispartof Biomarkers in medicine, 2017-02, Vol.11 (2), p.141-149
issn 1752-0363
1752-0371
language eng
recordid cdi_futurescience_futuremedicine_10_2217_bmm_2016_0283
source PubMed Central
subjects papillary thyroid carcinoma
risk
rs153109
rs17855750
single nucleotide polymorphism
title Association between
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-13T09%3A48%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-futurescience&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between&rft.jtitle=Biomarkers%20in%20medicine&rft.au=Nie,%20Xinwen&rft.date=2017-02-01&rft.volume=11&rft.issue=2&rft.spage=141&rft.epage=149&rft.pages=141-149&rft.issn=1752-0363&rft.eissn=1752-0371&rft_id=info:doi/10.2217/bmm-2016-0283&rft_dat=%3Cfuturescience%3E10_2217_bmm_2016_0283%3C/futurescience%3E%3Cgrp_id%3Ecdi_FETCH-futurescience_futuremedicine_10_2217_bmm_2016_02833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true